To generate successful gene therapies that are capable of delivering nucleic acids to specific cells and tissues, scientists must carefully design their products. They can employ either recombinant ...

Countable Labs raises $26 million. Company shares plans for new products to support clinical testing applications and announces hire of sales leader.

Stanford researchers and their collaborators have revealed a new device that could change the way scientists conduct gene-editing experiments. The device, CRISPR-GPT, is an artificial intelligence lab ...

Gene editing technology is being widely deployed to generate precise data about disease-causing gene mutations and networks, helping to identify optimal therapeutic targets. These approaches are ...

LifeArc partners with Elpida Therapeutics to advance three gene therapies for ultra-rare neurodegenerative diseases in childrenLifeArc provides tailored clinical, translational and regulatory ...

MedTherapy was founded in the US in 2018 and incorporated in India in 2020, he said, and pointed to support from the late ...

The recent approval of Regeneron’s Otarmeni underscores the maturation of gene therapies across a range of diseases. Here, ...

PHILADELPHIA--(BUSINESS WIRE)--Latus Bio, Inc. (“Latus”), a biotechnology company developing novel gene therapy candidates for disorders of the central nervous system (CNS), today announced its launch ...

Pancreatitis is a complex inflammatory disease driven by both genetic and environmental factors. It poses substantial ...

Tinkering with the genetic code of a living human is risky. The post Gene Therapy Causes Patient to Grow Alarming Tumor ...